{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:57:26Z","timestamp":1762505846618,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.revmed.2011.10.003","type":"journal-article","created":{"date-parts":[[2011,11,11]],"date-time":"2011-11-11T23:58:09Z","timestamp":1321055889000},"page":"200-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Manifestations dermatologiques du syndrome des antiphospholipides"],"prefix":"10.1016","volume":"33","author":[{"given":"C.","family":"Franc\u00e8s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Barete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Soria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2011.10.003_bib0005","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2230.1984.tb00856.x","article-title":"The Prosser-White oration 1983. Connective tissue disease and the skin","volume":"9","author":"Hughes","year":"1984","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.revmed.2011.10.003_bib0010","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000\u00a0patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2011.10.003_bib0015","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/art.21041","article-title":"Dermatologic manifestations of the antiphospholipid syndrome: two hundred consecutive cases","volume":"52","author":"Frances","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2011.10.003_bib0020","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1177\/0961203307077108","article-title":"Antiphospholipid syndrome in Latin American patients: clinical and immunologic characteristics and comparison with European patients","volume":"16","author":"Garcia-Carrasco","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2011.10.003_bib0025","first-page":"2379","article-title":"Livedo racemosa: a striking dermatological sign for the antiphospholipid syndrome","volume":"33","author":"Uthman","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2011.10.003_bib0030","first-page":"499","article-title":"Livedo reticularis is a marker for predicting multi-system thrombosis in antiphospholipid syndrome","volume":"23","author":"Toubi","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2011.10.003_bib0035","doi-asserted-by":"crossref","first-page":"e1100","DOI":"10.1542\/peds.2008-1209","article-title":"Pediatric antiphospholipid syndrome: clinical and immunologic features of 121\u00a0patients in an international registry","volume":"122","author":"Avcin","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.revmed.2011.10.003_bib0040","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00005792-199907000-00001","article-title":"Sneddon syndrome with or without antiphospholipid antibodies. A comparative study in 46\u00a0patients","volume":"78","author":"Frances","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2011.10.003_bib0045","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.hoc.2007.10.011","article-title":"Cutaneous manifestations of antiphospholipid antibody syndrome","volume":"22","author":"Weinstein","year":"2008","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.revmed.2011.10.003_bib0050","first-page":"416","article-title":"Thrombosis in systemic lupus erythematosus despite circulating anticoagulants","volume":"62","author":"Bowie","year":"1963","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.revmed.2011.10.003_bib0055","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00005792-198911000-00003","article-title":"Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500\u00a0consecutive patients","volume":"68","author":"Alarcon-Segovia","year":"1989","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2011.10.003_bib0060","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2133.1999.02622.x","article-title":"Livedoid vasculitis: a manifestation of the antiphospholipid syndrome?","volume":"140","author":"Acland","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.revmed.2011.10.003_bib0065","first-page":"1003","article-title":"Atrophie blanche \u00ab\u00a0idiopathique\u00a0\u00bb","volume":"128","author":"Tran","year":"2001","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.revmed.2011.10.003_bib0070","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/000331979804900209","article-title":"Pyoderma gangrenosum and extensive caval thrombosis associated with the antiphospholipid syndrome \u2013 a case report","volume":"49","author":"Chacek","year":"1998","journal-title":"Angiology"},{"key":"10.1016\/j.revmed.2011.10.003_bib0075","first-page":"45","article-title":"Pyoderma gangrenosum associated with the secondary antiphospholipid syndrome","volume":"8","author":"Schmid","year":"1998","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.revmed.2011.10.003_bib0080","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.revmed.2011.10.003_bib0085","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0002-9343(99)80355-6","article-title":"Trousseau's syndrome with nonbacterial thrombotic endocarditis: pathogenic role of antiphospholipid syndrome","volume":"98","author":"Bessis","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.revmed.2011.10.003_bib0090","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1056\/NEJMicm073564","article-title":"Images in clinical medicine. Retiform purpura","volume":"358","author":"Lipsker","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2011.10.003_bib0095","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0190-9622(00)90269-X","article-title":"Reactive angioendotheliomatosis in association with the antiphospholipid syndrome","volume":"42","author":"Creamer","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.revmed.2011.10.003_bib0100","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s12016-007-0011-1","article-title":"Primary anetoderma and antiphospholipid antibodies--review of the literature","volume":"32","author":"Hodak","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.revmed.2011.10.003_bib0105","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.1468-3083.2001.00255.x","article-title":"Anetoderma associated with antiphospholipid antibodies: case report and review of the literature","volume":"15","author":"Romani","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.revmed.2011.10.003_bib0110","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0190-9622(03)02110-8","article-title":"Anetoderma and its prothrombotic abnormalities","volume":"49","author":"Sparsa","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.revmed.2011.10.003_bib0115","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000246547","article-title":"Antiphospholipid antibodies and anetoderma: are they associated?","volume":"191","author":"Stephansson","year":"1995","journal-title":"Dermatology"},{"key":"10.1016\/j.revmed.2011.10.003_bib0120","doi-asserted-by":"crossref","unstructured":"Moulis G, Delavigne K, Huguet F, Fortenfant F, Beyne-Rauzy O, Adoue D. Profil des anticorps antiphospholipides et risque de thrombose\u00a0: \u00e9tude comparative entre thrombop\u00e9nie immunologique chronique et syndrome des antiphospholipides primaire. Rev Med Interne, 2011 Aug 22. [Epub ahead of print] French. doi:10.1016\/j.revmed.2011.07.014.","DOI":"10.1016\/j.revmed.2011.07.014"},{"key":"10.1016\/j.revmed.2011.10.003_bib0125","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1001\/archderm.1987.01660290064017","article-title":"Livedo reticularis associated with increased titers of anticardiolipin antibodies in systemic lupus erythematosus","volume":"123","author":"Weinstein","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2011.10.003_bib0130","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/jaut.2000.0423","article-title":"Kidney involvement in the antiphospholipid syndrome","volume":"15","author":"Nochy","year":"2000","journal-title":"J Autoimmun"},{"key":"10.1016\/j.revmed.2011.10.003_bib0135","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/0961203306075977","article-title":"Clusters of disease manifestations in patients with antiphospholipid syndrome demonstrated by factor analysis","volume":"16","author":"Krause","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2011.10.003_bib0140","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/096120339400300212","article-title":"Multiple subungual splinter hemorrhages in the antiphospholipid syndrome: a report of five cases and review of the literature","volume":"3","author":"Frances","year":"1994","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2011.10.003_bib0145","first-page":"508","article-title":"The catastrophic antiphospholipid syndrome","volume":"19","author":"Asherson","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2011.10.003_bib0150","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00005792-199805000-00005","article-title":"Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50\u00a0patients","volume":"77","author":"Asherson","year":"1998","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2011.10.003_bib0155","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s12016-008-8108-8","article-title":"Clinical and laboratory features of the catastrophic antiphospholipid syndrome","volume":"36","author":"Stojanovich","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.revmed.2011.10.003_bib0160","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s12016-007-0004-0","article-title":"Livedo reticularis as a criterion for antiphospholipid syndrome","volume":"32","author":"Toubi","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.revmed.2011.10.003_bib0165","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(10)60709-X","article-title":"Antiphospholipid syndrome","volume":"376","author":"Ruiz-Irastorza","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2011.10.003_bib0170","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.autrev.2006.06.013","article-title":"Therapeutic and prognostic considerations in catastrophic antiphospholipid syndrome","volume":"6","author":"Erkan","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2011.10.003_bib0175","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1001\/archderm.140.8.1011","article-title":"Difficult management of livedoid vasculopathy","volume":"140","author":"Frances","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.revmed.2011.10.003_bib0180","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1191\/0961203303lu257cr","article-title":"Treatment with sildenafil for the healing of refractory skin ulcerations in the antiphospholipid syndrome","volume":"12","author":"Gertner","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.revmed.2011.10.003_bib0185","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1136\/ard.2008.093179","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000\u00a0patients","volume":"68","author":"Cervera","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2011.10.003_bib0190","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S0190-9622(97)70045-8","article-title":"Widespread cutaneous necrosis and antiphospholipid antibodies: two episodes related to surgical manipulation and urinary tract infection","volume":"36","author":"Del Castillo","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.revmed.2011.10.003_bib0195","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1182\/blood-2008-03-144204","article-title":"Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers","volume":"112","author":"Rand","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2011.10.003_bib0200","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.revmed.2010.08.018","article-title":"Hydroxychloroquine: une nouvelle approche therapeutique des manifestations thrombotiques du syndrome des antiphospholipides","volume":"31","author":"Szymezak","year":"2010","journal-title":"Rev Med Interne"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866311007399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866311007399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:29:29Z","timestamp":1759336169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866311007399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0248866311007399"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2011.10.003","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Manifestations dermatologiques du syndrome des antiphospholipides","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2011.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Soci\u00e9t\u00e9 nationale Fran\u00e7aise de m\u00e9decine interne (SNFMI). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}